Project description
Microbiota and microglial interaction in Alzheimer’s disease progression
Alzheimer’s disease (AD) affects over 55 million people globally and has no effective treatment. Microglial cells involved in amyloid-beta clearance and neuroinflammation play a key role in AD progression. Recent evidence suggests that gut microbiota may influence these cells, but the mechanisms underlying the role of the gut-microbiota-brain axis in AD remain unclear. With the support of the Marie Skłodowska-Curie Actions programme, the MiMi-AD project will elucidate how gut microbiota regulates microglial reactivity in AD progression, using the Tg2576 mouse model. It will investigate whether exercise-induced changes in gut microbiota can facilitate microglial cells in enhancing amyloid-beta (Aβ) clearance, slowing cognitive decline and reducing neuroinflammation. Findings may support new biomarker identification and new therapeutic strategies for delaying AD onset.
Objective
Alzheimer’s disease (AD) affects over 55 million people worldwide, with no effective treatments currently available. Understanding early-stage mechanisms of the disease is critical to developing new therapeutic approaches. Microglial cells, key regulators of amyloid-beta (Aβ) clearance and neuroinflammation, are implicated in the progression of AD. Emerging evidence suggests that the gut microbiota, through its influence on microglial function, may play a pivotal role in AD pathogenesis. However, the precise regulatory mechanisms of the gut-microbiota-brain axis in AD remain unexplored.
The MiMi-AD project, aims to elucidate the role of gut microbiota in modulating microglial activity across AD progression stages, using the Tg2576 mouse model of AD. Specifically, the project will investigate whether exercise-induced alterations in gut microbiota can prime microglial cells to promote Aβ clearance, delay cognitive decline, and reduce neuroinflammation. The research will employ cutting-edge transcriptomics, metabolomics, and microbiota analysis to explore these dynamic interactions, along with in vivo and in vitro studies to identify targetable microbial metabolites.
The outcomes of this research could identify novel gut-brain axis pathways, providing a foundation for therapeutic strategies aimed at delaying the onset of AD. Through interdisciplinary collaboration, this project aligns with European and global priorities in promoting healthy aging, offering potential benefits for individuals at risk of developing AD.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
You need to log in or register to use this function
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-MSCA-2024-PF-01
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
75794 PARIS
France
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.